ArticleAnnals of the rheumatic diseases2017

Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.

Cristina Rozo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.